Bladder Cancer (eBook)

Part I. Improving Bladder Cancer Staging

Section 1. CIS

Chapter 1. Approach to CIS
J. Stephen Jones, MD
Chapter 2. Fluorescent Cystoscopy
H. Barton Grossman, MD
Section 2. Understaging

Chapter 3. Restaging TURBT
Jeffrey Holzberlein, MD
Chapter 4. Understaging T2: Limitations of Pelvic Imaging
Richard Cohan, MD
Chapter 5. MRI Endorectal Coil
Saroja Adusumilli, MD
Chapter 6. PET Imaging: Advances in the Detection of Locally Advanced and Nodal Disease
Morand Piert, MD
Chapter 7. Detection of Extravesical Disease: A Lack of Bladder Cancer Markers
Sam S. Chang, MD
Chapter 8. Identification of Nodal Metastases: The Role of Iron Oxide Enhanced MRI

Bernard Bochner, MD
Chapter 9. Presence and Significance of Micrometastases

Douglas Scher, MD
Part II. Optimizing Treatment of Localized Disease

Section 1: Intravesical Therapy

Chapter 10. Peri-operative intravesical therapy

Ed Messing, MD
Chapter 11. BCG Refractory Disease

Graham Greene, MD
Chapter 12. Beyond BCG: Gemcitabine

Guido Dalbagni, MD
Chapter 13. Beyond BCG: Taxanes

James McKiernan, MD
Section 2: Cystectomy: Cancer Control and Organ Preservation

Chapter 14. Extended Lymph Node Dissection

Marcus Quek, MD
Chapter 15. Prostate Capsule Sparing Cystectomy
Alon Weizer, MD
Chapter 16. Preservation of Reproductive Organs in Women

Gary Steinberg, MD
Chapter 17. Nerve Sparing Cystectomy

Mark Schoenberg, MD
Chapter 18. Quality of Care Indicators for Radical Cystectomy

Badrinath R. Konety, MBBS, MBA
Section 3: Continent Diversion: Problems and Solutions

Chapter 19. Continent Diversion: QOL of Orthotopic Diversion vs Ileal Conduit

Scott Gilbert, MD
Chapter 20. Voiding Dysfunction After Orthotopic Diversion

Jerilyn Latini, MD
Chapter 21. Overcoming the Stigma of Complications of Continent Cutaneous Diversion

Tom Gardner, MD
Part III. Locally Advanced / Distant Disease: Multi-Modality treatment
Chapter 22. Neoadjuvant Chemotherapy: The New Standard

Primo Lara, MD
Chapter 23. Adjuvant Therapy: A Good Concept But Where’s the Proof

Timothy Gilligan, MD
Chapter 24. Beyond MVAC: New and Improved Chemotherapeutics

Maha Hussain, MD
Part IV: Next Steps: Translational Research

Chapter 25. The Role of Microarray Technologies in Bladder Cancer Management

Marta Sanchez-Carbayo, PhD
Chapter 26. Development of Novel Agents / Targeted Therapies

Dan Theodorescu, MD
Chapter 27. Tools for Study: National Databanking

Randall Miliken, MD
Chapter 28. Vaccine Development
John Coleman, MD
Chapter 29. Advances in Gene Therapy for Bladder Cancer

Tom Gardner, MD